Vaishali Pharma will take over the domestic and international marketing operations of Sankalp Life Care, agreement signed between the two companies

Mr. Atul Vasani, Managing Director – Vaishali Pharma Ltd.

Ahmedabad (Gujarat) [India], April 20: Ahmedabad-based Sankalp Life Care, a leading manufacturer of nutraceuticals, and Mumbai-headquartered Vaishali Pharma Ltd., a leading manufacturer and exporter of pharma formulations, have come together to form a unique partnership that will help both companies grow faster.

As per the agreement between the two companies, NSE-listed Vaishali Pharma Ltd. will take over the entire domestic and international marketing of Sankalp Life Care’s portfolio of nutraceutical products.

“This is a perfect partnership. Sankalp Life Care’s core strength is in manufacturing the best quality nutraceutical products, and Vaishali Pharma has a wide global presence in the Indian and multiple markets and specializes in marketing. The partnership will allow us to leverage Vaishali Pharma’s marketing reach and focus on our expertise. It is a win-win for both companies, and we look forward to growing together and offering the highest-quality nutraceutical products to customers in India and around the world,” said Dimple Goenka, Director, Sankalp Life Care.

Mrs. Dimple Goenka, Director – Sankalp Life Care

“This agreement between Vaishali Pharma and Sankalp Life Care is the first-of-its-kind in the Indian Pharma Industry. Vaishali Pharma will handle the complete domestic and international marketing operations of Sankalp Life Care and make Sankalp Life Care’s 100+ innovative products available in more than 40 countries. The unique agreement builds on the strengths of the two companies and will be mutually beneficial,” said Atul Vasani, Managing Director, Vaishali Pharma Ltd.

Sankalp Life Care is a leading nutraceuticals company and has set up the 5th largest nutraceuticals facility in the country at Bavla, Ahmedabad. A range of tablets, capsules, powders, sachets, gummies, liquid and effervescent tablets, among other products, are made at the zero-discharge facility, which is fully operational now and has been designed as per standards defined by World Health Organisation. It is also designed as per USFDA standards, and the company has already made an application for USFDA approval for the facility.

Vaishali Pharma, which manufactures and exports pharma formulations in a wide spectrum of dosage forms & therapeutic segments, Active Pharmaceutical Ingredients (APIs), surgical products, nutraceutical, and oncology products, is one of the fastest-growing and most versatile companies in the industry. It has a strong presence in both the domestic and export markets and is currently a supplier to all leading Indian and multinational pharmaceutical companies. The company has been catering to semi-regulated and non-regulated markets across the globe.

www.vaishalipharma.com

Related Posts

Business Excellence Awards 2024 organized by Corporate Connect

New Delhi (India), May 25: It is time to recognize and celebrate the extraordinary business innovation and entrepreneurship achievements. Corporate Connect is thrilled to announce the winners of its highly…

IB Group Emerges as Top 5 Poultry Company in Asia

New Delhi (India), May 25: In a resounding testament to its remarkable growth trajectory, IB Group, in collaboration with Aviagen®, proudly announces a significant milestone: the acquisition of 100,000 Grandparent Poultry (GP) stock in a…

You Missed

Dr. Krishna Kumar Mourya ji has selflessly served cows for 20 years and has set a world record by conducting post-mortems of more than 3000 cows

  • May 25, 2024
Dr. Krishna Kumar Mourya ji has selflessly served cows for 20 years and has set a world record by conducting post-mortems of more than 3000 cows

Flomic Global Logistics Achieves Landmark Milestone with Make in India Gondola Freight Wagons Shipment to Africa

  • May 25, 2024
Flomic Global Logistics Achieves Landmark Milestone with Make in India Gondola Freight Wagons Shipment to Africa

Morepen Labs Profit surges 143 percent while Revenue grows 20 percent in FY24, Dr. Morepen Medical Devices sales soar by 35 percent

  • May 25, 2024
Morepen Labs Profit surges 143 percent while Revenue grows 20 percent in FY24, Dr. Morepen Medical Devices sales soar by 35 percent

Testronix Instruments Announces Revolutionary Testing Solutions

  • May 24, 2024
Testronix Instruments Announces Revolutionary Testing Solutions

SEO on a Budget, This Free Toolkit is All You Need

  • May 24, 2024
SEO on a Budget, This Free Toolkit is All You Need

Orientation Training Programme for Arb-Med

  • May 24, 2024
Orientation Training Programme for Arb-Med